Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Will Alkermes Data Package Support ALKS 5461 Approval?
Alkermes Antidepressant Rejected by FDA | ALKS 5461 - YouTube
ALKS 5461 Study for Major Depression | PDF | Antipsychotic | Major ...
Secondary structure of the alkS mRNA leader region and effect of Crc ...
NUR 5461 Chapter 28: Hematologic System Structure and Function Overview ...
ALKS 5461 receives refusal-to-file for depression: industry news round ...
ALKS 5461 accepted for review following previous refusal-to-file for ...
ALKS 5461 accepted by FDA in reversal of earlier refusal : r ...
Keeping ALKS 5461 Out of the Spotlight? | Faith Seeking Understanding
Alkermes Receives Complete Response Letter From FDA for ALKS 5461 New ...
RCSB PDB - 6VWU: X-ray structure of ALKS 4230, a fusion of circularly ...
ALKS 5461: A Novel, Functional KappaAntagonistBuprenorphineALKS 33ALKS ...
ALKS 5461:Functional Kappa Antagonist44
ALKS 5461获美国FDA快速审批资格，用于治疗重度抑郁症（MDD） | 美中药源
ALKS 5461: A Novel, Functional KappaAntagonistBuprenorphineALKS 33 ...
ALKS 5461: Phase 1b Study for CocaineAddiction Underway; Funded by NIDA50
ALKS 4230: a novel engineered IL-2 fusion protein with an improved ...
Transcription of the alkS gene. The alkS gene can be transcribed from ...
Function of the alk regulatory system and structure of the genetic ...
Structure of ALK kinase domain. (A) Two mutation sites in this study ...
Chemical structure of A Acid Blue 113 and B Reactive Blue 160 ...
Alkermes third time lucky with ALKS 5461, but doubts linger | Fierce ...
The structure of the coding region of SSIIa gene and the positions for ...
ALEKS: Identifying a chiral molecule from its condensed structure - YouTube
AI protein structure prediction-based modeling and mutagenesis of a ...
ChemAIRS accelerates the Discovery of Synthetic Routes for ALKS 2680 ...
Identification of KLC1-ALK. Panel A shows the schematic structure of ...
CX-5461 selectively inhibits rRNA synthesis. A, structure of CX-5461 ...
Alkyne Alkene Alkane Structure
Alks 2680 – Application in Therapy and Current Clinical Research
ALKS 2680，发作性睡病，嗜睡症候群
ALKS 37 Significantly Improves Bowel Functionp=0.006*Weekly SBM (change ...
Structure of invertebrate ALK’s EGF-like domains a, The first EGF-like ...
(PDF) O013 Preliminary Results from a Phase 1 Study of ALKS 2680, an ...
Structure of the central genetic elements constructed in this study ...
ALKs and AMHR-II expression in SMAT-1 cells. Total RNAs were isolated ...
ALKS Historical PE Ratio
Slide 48
Slide 47
buprenorphine/samidorphan (ALKS 5461) / Alkermes
Slide 46
Slide 45
Slide 50
alixorexton (ALKS 2680)
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor ...
CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth ...
Drug that targets the opioid system support its safety and ...
Biotech stock Alkermes plunges 20% after FDA refuses to review its ...
Slide 49
Neumora Therapeutics: A Story Of A Class II Biotech (NASDAQ:NMRA ...
Alkermes plc | $ALKS Stock | Shares Climb Up On Positive Phase 3 Study ...
Alkermes Announces Topline Results of FORWARD-3 and FORWARD-4, Two ...
阿尔科姆斯公司向FDA递交ALKS 5461新药申请，用于重度抑郁障碍的辅助治疗
Slide 15
Alixorexton (ALKS 2680) is an oral small-molecule OXR2 agonist from ...
CX-5461 - Pol I rRNA Synthesis Inhibitor | APExBIO
Molecular basis of CX-5461-induced DNA damage response in primary ...
Sequential Parallel Comparison Design Elaine Hoffman Ph D
A schematic of molecular response to CX-5461. CX-5461 inhibits RNA ...
CX-5461 (Pidnarulex) | RNA Polymerase I Inhibitor | CAS 1138549-36-6 ...
In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan ...
CX-5461 dihydrochloride | RNA Polymerase I Inhibitor | MedChemExpress
Slide 14
Slide 12
The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I ...
Exhibit 99.2
EDGAR Filing Documents for 0000950170-23-054999
Slide 13
Slide 8
Alkermes Depression Drug Fails In Studies, Shares Plunge
CX-5461 | DNA/RNA Synthesis | TargetMol
行业报告 | 首次！2025年12款小分子新药结构揭晓 - 知乎
Slide 9
CX-5461 | CAS 1138549-36-6 | SCBT - Santa Cruz Biotechnology
Structures and ALK inhibitory activities of compounds 21 and 22 ...
CX-5461 causes DNA damage in colorectal cancer cells. a Total lysates ...
Slide 18
Slide 4
Slide 44
ADAS/AD系统开发22-新版ALKS功能定义（1） - 知乎
AKS461 is localized in the lysosome. Dual color live-cell visualization ...
Slide 7
CX5461 | rRNA 合成抑制剂 | 激活 DNA 损伤反应 | 抗肿瘤 | TargetMol
Individual and Combined Effects of Reinforcements on Fractured Surface ...
Slide 16
5461-06-3 - CAS号查询
Crizotinib binding modes in ALKs: (A) WT, (B) L1198F mutant, (C) G1202R ...
Slide 5
CX-5461 (Pidnarulex) | CAS 1138549-36-6 | AbMole BioScience | CX-5461 Price
Premium Photo | Steel girders intertwined like veins supporting the ...
Slide 42
Two 1D Chain Structures Derived from Alkaline-Earth Metal Complexes and ...
Slide 43
Alkermes shares take another hit as the FDA shakes its head — again ...
ALK Fusion Partners Impact Response to ALK Inhibition: Differential ...
Discovery of a small molecule targeting ULK1-modulated cell death of ...
(PDF) A G-quadruplex stabilizer, CX-5461 combined with two immune ...
Biorbyt
EDGAR Filing Documents for 0000950170-25-113379
The Carlat Psychiatry Blog: Antidepressant News: Just the Right Amount ...
Monomethyl fumarate | MedChemExpress (MCE) Life Science Reagents
FDA dismisses Alkermes’ pitch on ‘5461, demanding new depression trials ...
